Cargando…
Comment: Comparison of efficacy, safety and cost-effectiveness of various statins in dyslipidemic diabetic patients
Autores principales: | Hadigal, Sanjay, Ashok Shenoy, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118551/ https://www.ncbi.nlm.nih.gov/pubmed/25097296 http://dx.doi.org/10.4103/0253-7613.135970 |
Ejemplares similares
-
Comparison of efficacy, safety, and cost-effectiveness of various statins in dyslipidemic diabetic patients
por: Bener, Abdulbari, et al.
Publicado: (2014) -
Response to comment on: Statin use and risk of diabetes mellitus
por: Chogtu, Bharti, et al.
Publicado: (2016) -
Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients
por: Barakat, Lolwa, et al.
Publicado: (2013) -
The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
por: Nartea, Roxana, et al.
Publicado: (2023) -
A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy
por: Needamangalam Balaji, Jyotsna, et al.
Publicado: (2022)